Pembrolizumab monotherapy in metastatic triple-negative breast cancer. Amir E, Cescon DW. Lancet Oncol 2021 Mar 4. pii: S1470-2045(21)00019.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Amir E, Cescon DW. Pembrolizumab monotherapy in metastatic triple-negative breast cancer. Lancet Oncol 2021 Mar 4. pii: S1470-2045(21)00019.
PMID: 33676605